Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:302-309
Published online before print January 10, 2005, doi: 10.1161/01.CIR.0000153351.86708.F7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/3/302    most recent
01.CIR.0000153351.86708.F7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, S.
Right arrow Articles by Matsumura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, S.
Right arrow Articles by Matsumura, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Genetics of cardiovascular disease
Right arrow Lipid and lipoprotein metabolism

(Circulation. 2005;111:302-309.)
© 2005 American Heart Association, Inc.


Heart Failure

Different Contributions of Endothelin-A and Endothelin-B Receptors in Postischemic Cardiac Dysfunction and Norepinephrine Overflow in Rat Hearts

Satoshi Yamamoto, MSc; Noriko Matsumoto, MSc; Mitsuo Kanazawa, BSc; Marie Fujita, BSc; Masanori Takaoka, PhD; Cheryl E. Gariepy, MD; Masashi Yanagisawa, MD, PhD; Yasuo Matsumura, PhD

From the Department of Pharmacology (S.Y., N.M., M.K., M.F., M.T., Y.M.), Osaka University of Pharmaceutical Sciences, Osaka, Japan; Department of Pediatrics (C.E.G.), University of Michigan, Ann Arbor, Mich; and Howard Hughes Medical Institute (M.Y.), Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Tex.

Reprint requests to Yasuo Matsumura, PhD, Department of Pharmacology, Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-1094, Japan. E-mail matumrh{at}gly.oups.ac.jp

Received April 22, 2004; revision received August 10, 2004; accepted October 5, 2004.

Background— Endothelin (ET)-1 and norepinephrine (NE) are involved in myocardial ischemia/reperfusion injury. We investigated the role of ET-1 in ischemia/reperfusion–induced NE overflow and cardiac dysfunction using a selective ETA receptor antagonist (ABT-627), a selective ETB receptor antagonist (A-192621), and the spotting lethal (sl) rat, which carries a naturally occurring deletion in the ETB receptor gene.

Methods and Results— According to the Langendorff technique, isolated hearts were subjected to 40-minute global ischemia followed by 30-minute reperfusion. In Sprague-Dawley rat hearts, ischemia/reperfusion–induced cardiac dysfunctions such as decreased left ventricular developed pressure and coronary flow and increased left ventricular end-diastolic pressure were worsened by treatment with A-192621. This agent enhanced excessive NE overflow in the coronary effluent from the postischemic heart. In contrast, treatment with ABT-627, in the absence or presence of A-192621, significantly improved postischemic cardiac dysfunction and markedly suppressed NE overflow to the same extent. Postischemic cardiac dysfunction and NE overflow in the heart of ETB receptor–deficient homozygous (sl/sl) rats were highly observed compared with cases in wild-type rats, and exaggerated responses to ischemia/reperfusion in sl/sl rats were abolished by ABT-627 treatment. Exogenously applied ET-1 produced severe cardiac dysfunction and a significant increase in NE overflow in a dose-dependent manner, but these responses were markedly suppressed in the presence of 5-N-ethyl-N-isopropyl-amiloride, an inhibitor of the Na+/H+ exchanger (NHE).

Conclusions— Pharmacological blockade or genetic deficiency of ETB receptors is detrimental to the postischemic heart, and exaggerated cardiac pathology under the above conditions is mediated by ETA receptor activation. ETA/NHE-mediated excessive NE overflow is contributive, at least in part, to postischemic cardiac dysfunction in rats.


Key Words: endothelin • ischemia • norepinephrine • reperfusion




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
V. A. Rufanova, V. F. Pozdnev, E. I. Kalenikova, A. B. Postnikov, A. N. Storozhilova, V. P. Masenko, O. A. Gomazkov, O. S. Medvedev, and N. A. Medvedeva
Endothelin-Converting Enzyme Inhibition in the Rat Model of Acute Heart Failure: Heart Function and Neurohormonal Activation
Experimental Biology and Medicine, October 1, 2009; 234(10): 1201 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. D.W. van der Bilt, M. E. Soeters, A. M.M.J. Duyverman, M. W. Nijkamp, P. O. Witteveen, P. J. van Diest, O. Kranenburg, and I. H.M. Borel Rinkes
Perinecrotic Hypoxia Contributes to Ischemia/Reperfusion-Accelerated Outgrowth of Colorectal Micrometastases
Am. J. Pathol., April 1, 2007; 170(4): 1379 - 1388.
[Abstract] [Full Text] [PDF]